Visit Days 2021
February 22, 2021 | Department News

2021 Admitted Student Visit Days Events

Graduate students admitted to the UW Department of  Global Health are invited to join department faculty, students and staff in March to learn more about the department's graduate programs, life in Seattle, and becoming a part of the UW global health community. Admitted students interact with DGH faculty, current students, and alumni and discuss their experiences in global health research, learning, service and career paths.

Four Visit Days events are open to DGH current students as well as 2021 admitted students:

Global Healthies
January 29, 2021 | Department News

Global Healthies Student Opportunities Fair, Jan. 25 - Feb. 5

UW Global Health students: DGH faculty and staff want to collaborate with YOU! Gain first-hand experience on global health projects!

Below are current and upcoming projects from DGH researchers and staff who are looking for students to get involved! DGH will hold networking sessions between January 25 and February 5 where students can discuss project opportunities with relevant faculty/staff.

Ruanne Barnabas COVID-19 vaccine
January 04, 2021 | Department News

Opinion: Specialists Back Single-Dose Vaccine Strategy for COVID-19 (includes Ruanne Barnabas)

Even partial protection of one dose could be enough to slow the spread of the virus, the UW Medicine researchers argue in a paper.

MEDIA CONTACT: Susan Gregg - 206.616.6730, sghanson@uw.edu

Giving one dose of the COVID-19 vaccines currently approved in the United States could curtail the spread of the SARS-CoV-19 in the community more quickly than the recommended two doses, say two vaccine experts at the University of Washington School of Medicine.

COVID-19 vaccine Scott McClelland
December 30, 2020 | Department News

UW Medicine starts Novavax COVID-19 vaccine clinical trial (includes Scott McClelland)

Volunteer enrollment begins for Phase III clinical trial that will determine the efficacy of Novavax vaccine candidate.

UW Medicine investigators are starting volunteer enrollment for an investigational COVID-19 vaccine clinical trial. The Phase III study will examine whether the Novavax vaccine candidate can protect against SARS-CoV-2, the coronavirus responsible for COVID-19.

COVID-19 vaccine
December 24, 2020 | Department News

How Safe and Effective Are the New Coronavirus Vaccines?

The U.S. Food and Drug Administration (FDA) has granted emergency use for two new coronavirus vaccines, one developed by the drug company Pfizer and the biotech company BioNTech and the other by the biotech company ModernaTX. Both are mRNA vaccines and have similar structure.

Both vaccines contain modified mRNA that provides the instructions for the synthesis of the SARS-CoV-2 spike glycoprotein antigen. Its mRNA is enveloped in lipid nanoparticles (LNPs) to prevent degradation and enhance uptake into cells.

Pages